Login to Your Account



Financings Roundup

Oncology Start-up Firm Peloton Closes $18M Series A Financing

By Jennifer Boggs


Thursday, July 28, 2011
Recently formed early stage cancer drug company Peloton Therapeutics Inc. raised $18 million in a Series A financing that reunited Tularik Inc. co-founders Steven L. McKnight and David Goeddel.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription